ONWARD Medical Announces Webcast for Business Update
ONWARD Medical N.V. (Euronext: ONWD), a groundbreaking medical technology firm focused on spinal cord stimulation therapies, is preparing to host a webcast. This event will highlight key business developments from the first half of 2024, offering insights into advancements that support movement and enhance independence for those affected by spinal cord injuries (SCI).
Webcast Details
The webcast is scheduled for September 10 at 2:00 PM CET / 08:00 AM ET. CEO Dave Marver will guide the session, sharing important updates on the company’s current projects and innovative future plans. Attendees are encouraged to participate and learn about ONWARD's progress in the medical field.
How to Join the Webcast
Participants can join the session via Zoom, making it accessible to both the healthcare community and the general public. For those who prefer to join by phone, ONWARD has provided several international dial-in numbers:
- Belgium: +32 2 290 9360
- France: +33 1 7095 0350
- Germany: +49 69 3807 9884
- Netherlands: +31 20 794 0854
- Switzerland: +41 22 591 0156
- United Kingdom: +44 203 481 5240
- United States: +1 346 248 7799
A recording of the webcast will be available on the company’s website shortly after the live event, ensuring that those who are unable to attend can still access the essential information.
Commitment to Innovation
ONWARD Medical is committed to collaborating with the spinal cord injury community to create advanced solutions aimed at restoring movement and functionality. The company is particularly focused on initiatives like ARC Therapy™, an innovative treatment that has garnered multiple Breakthrough Device Designations from the FDA, highlighting its potential to improve patient outcomes.
About ONWARD Medical
Based in Eindhoven, ONWARD Medical has built a solid reputation in the medical technology field by developing therapies designed to restore bodily functions affected by SCI. Their flagship treatment, ARC Therapy, represents a new generation of therapies that enhance mobility through targeted spinal cord stimulation. This is achieved using systems such as the ARC-IM® and ARC-EX®, offering renewed hope to patients around the globe.
Recent clinical trials, particularly the Up-LIFT study, showcased the effectiveness of non-invasive ARC-EX Therapy in significantly improving upper limb functions among participants. With regulatory applications submitted in both the US and Europe, ONWARD is leading the charge for the future of SCI treatments.
Global Reach
ONWARD Medical maintains a strong international presence, featuring a dedicated Science and Engineering Center in Lausanne, Switzerland, and an operational office in Boston, Massachusetts. The company's dedication to innovation and quality has solidified its standing in the industry, further bolstered by its listing on Euronext Brussels and Amsterdam under the ticker symbol ONWD.
Contact Information
For additional inquiries, ONWARD Medical encourages communication through the following channels:
For Media Inquiries:
Aditi Roy, VP Communications
Email: media@onwd.com
For Investor Inquiries:
Amori Fraser, Finance Director
Email: investors@onwd.com
Frequently Asked Questions
What is the purpose of the upcoming webcast by ONWARD Medical?
The webcast aims to share insights into ONWARD Medical's business highlights from the first half of 2024 and updates on innovative therapies for spinal cord injury.
When will the webcast take place?
The webcast is set for September 10 at 2:00 PM CET / 08:00 AM ET.
Who will host the webcast?
CEO Dave Marver will lead the presentation during the webcast.
How can participants join the webcast?
Participants can join the webcast via Zoom, and there are several international phone numbers available for those who prefer to dial in.
What is ARC Therapy from ONWARD Medical?
ARC Therapy is an innovative spinal cord stimulation treatment developed by ONWARD Medical, designed to restore movement and function in individuals with spinal cord injuries.
